Orbimed Capital II LLC insider trades: Supernus Pharmaceuticals (SUPN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Orbimed Capital II LLC reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 13, 2013 | SUPN | ↓ Sell | 302,183 | $7.55 | $2.3M | Indirect | Feb 14, 2013 (1d) |
| Dec 18, 2012 | SUPN | ↓ Sell | 297,815 | $6.92 | $2.1M | Indirect | Dec 19, 2012 (1d) |
| May 4, 2012 | SUPN | ↑ Buy | 1,100,000 | $5.00 | $5.5M | Indirect | May 8, 2012 (4d) |
| May 31, 2006 | AVN | ↓ Sell | 629,121 | $9.79 | $6.2M | Fn | Jun 2, 2006 (2d) |
| May 24, 2006 | GIVN | ↓ Sell | 22,500 | $18.14 | $408K | FN 3 and 4 | May 26, 2006 (2d) |
| Jul 13, 2005 | CRYO | ↓ Sell | 135,000 | $11.00 | $1.5M | Fn, 1, 2, 3 | Jul 18, 2005 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SUPN insiders
Open-market trades in the last 12 months
About Orbimed Capital II LLC's insider trades
Orbimed Capital II LLC is a 10% owner of Supernus Pharmaceuticals (SUPN). Since Jul 13, 2005, it has reported 1 open-market purchase worth $5.5M and 5 sales worth $12.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (3 filings), other transactions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SUPN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.